金天格对去卵巢大鼠骨丢失的改善及成骨破骨调控机制
该研究在去卵巢大鼠中口服金天格或戊酸雌二醇12周,发现金天格提高骨密度、改善骨微结构和生物力学性能并逆转骨高转换;体外促进BMSCs成骨分化、上调BMP与Wnt/β-catenin通路蛋白,并抑制破骨细胞生成及NF-κB通路。
要点
- 金天格可提高去卵巢大鼠骨密度并改善骨微结构与生物力学性能。
- 金天格通过BMP与Wnt/β-catenin通路促进BMSCs成骨分化。
- 金天格通过抑制NF-κB通路抑制破骨细胞生成。
核心结论
- 金天格可预防去卵巢大鼠骨丢失,并通过调控成骨与破骨细胞形成和分化发挥防治骨质疏松的潜力。
研究设计与样本
- 去卵巢大鼠口服金天格或戊酸雌二醇12周的体内药效学研究,并结合体外BMSCs与BMM细胞实验。
主要发现
- 金天格提高去卵巢大鼠骨密度、改善骨微结构和生物力学性能,并逆转血清生化标志物反映的骨高转换。
- 金天格促进体外BMSCs成骨分化并上调BMP和Wnt/β-catenin通路关键蛋白表达。
- 金天格抑制RANKL和LPS诱导的破骨细胞生成,表现为TRAP活性、F-actin构建及NFATc1、c-Fos、Ctsk、MMP9表达改变,并降低破骨细胞NF-κB表达与磷酸化。
临床怎么用
- 金天格作为天然虎骨替代品,具有防治骨质疏松的潜力,其作用涉及促进成骨和抑制破骨的双重调控。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tiger bone, which had been one of the most famous traditional Chinese medicine for 2000 years, was originate from the skeleton of Panthera tigris L., and had the actions of anti-inflammatory, analgesic, immune-regulatory and promoting healing of bone fracture, and was used for the treatment of osteoporosis and rheumatoid arthritis. Jin-Tian-Ge (JTG), the artificial tiger bone powder, were prepared from skeletons of several farmed animals to substitute the natural tiger bone, and has been used for the treatment of osteoporosis in clinical practice. However, the characteristic and mechanism of action of JTG for the therapy of osteoporosis need to be further evidenced by using modern pharmacological methods. The aim of this work is to investigate the bone-protective effects of JTG, and explore the possible underlying mechanism. METHODS: Ovariectomy (OVX) rats were orally administrated JTG or estradiol valerate (EV) for 12 weeks. We investigated the pharmacodynamic effects of JTG on anti-bone loss in OVX rats, and also investigated the role of JTG in promoting osteogenesis and inhibiting osteoclast differentiation. RESULTS: JTG increased the bone mineral density (BMD), improved the bone microarchitecture and biomechanical properties in ovariectomized rast, whereas reversed the bone high turnover in OVX rats as evidenced by serum biochemical markers in OVX rats. JTG increased osteogenic differentiation of BMSCs in vitro, and up-regulated the expression of the key proteins of BMP and Wnt/β-catenin pathways. JTG also inhibited the osteoclastogenesis of BMM as evidenced by the alteration of the TRAP activity, F-actin construction and the expression of nuclear factor of activated T-cells cytoplasmic 1 (NFATc1), c-Fos, Cathepsin K (Ctsk) and matrix metallopeptidase 9 (MMP9) of OCs induced with RANKL and LPS, reduced the expression and phosphorylation of NF-κB in OCs. CONCLUSIONS: JTG prevented bone loss in OVX rats and increased osteogenic differentiation of BMSCs through regulation of the BMP and Wnt/β-catenin pathway, inhibited osteoclastogenesis by suppressing the NF-κB pathway, suggesting that JTG had the potentials for prevention and treatment of osteoporosis by modulating formation and differentiation of osteoblast and osteoclast.
引用
- Shen Y, Wang N, Zhang Q, et al. Jin-Tian-Ge ameliorates ovariectomy-induced bone loss in rats and modulates osteoblastogenesis and osteoclastogenesis in vitro. Chin Med. 2022. PMID: 36195960. doi:10.1186/s13020-022-00627-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。